Treating high cholesterol quickly and aggressively after a heart attack may help prevent thousands of new heart attacks and ...

Research shows improved survival outcomes with statin use in patients with chronic lymphocytic leukemia receiving ibrutinib treatment.

The study presents promising observations that could be good news for patients on statin and the pharma manufacturing the ...

With efforts being ramped up to slash heart attack and stroke risks, many doctors argue that taking statins over the age of ...

A new study suggests that people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) may live longer ...

A new study from the University of Pennsylvania’s Perelman School of Medicine shows that making 90-day prescriptions the default option in the electronic health system led to thousands more patients ...

Ten years after learning their polygenic risk score, patients had fewer events—perhaps due to greater use of statin therapy.

Not everyone is sold on the benefits of early ezetimibe use, especially given the modest effect seen in IMPROVE-IT.

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the start of their cancer treatment had a 61% lower risk ...

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering ...

Low low-density lipoprotein cholesterol levels are associated with a reduced risk for dementia, including Alzheimer disease-related dementia.